Melanoma Research Review, Issue 30

In this issue:

Association between irAEs and RFS among patients with stage III melanoma treated with pembrolizumab vs placebo
ASCO guidelines for systemic therapy for melanoma
Dabrafenib + trametinib for treatment of BRAF V600-mutated metastatic melanoma
Patterns of failure in patients with cutaneous head and neck melanoma
Thick melanomas without lymph node metastases and poor prognosis
Benefits of psychological intervention targeting fear of cancer recurrence in patient with melanoma
Clinicopathological factors associated with death from thin (≤ 1.00 mm) melanoma
The association between pesticide use and cutaneous melanoma

Please login below to download this issue (PDF)

Subscribe